Modified oligonucleotides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5112963
SERIAL NO

07270243

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides modified oligonucleotides, wherein, amongst the first four bases on the 5'-end, they have the base sequence AT or TA and, bound to one of the two O.sup.- groups of the 5'-phosphate group of the first nucleotide at the 5'-end of said oligonucleotide, they contain a radical of the general formula: ##STR1## in which R.sub.4 is a spacer group and R.sub.1, R.sub.2 and R.sub.3 are hydrogen atoms or alkyl or alkoxy radicals containing up to 3 carbon atoms. These modified oligonucleotides can be used for blocking the replication and/or expression of genes which have a sequence complementary with the modified oligonucleotides.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E VMUNICH GERMANY MUNICH BAVARIA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cramer, Friedrich Gottingen, DE 3 240
Englisch, Uwe Gottingen, DE 1 230
Pieles, Uwe Gottingen, DE 8 424

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation